Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma

Cancer Cell

Volumn 32, Issue 1, 2017, Pages 57-70.e3

  Chaisaingmongkol, Jittiporn ^a,b,n   Budhu, Anuradha ^a   Dang, Hien ^a   Rabibhadana, Siritida ^b   Pupacdi, Benjarath ^b   Kwon, So Mee ^a   Forgues, Marshonna ^a   Pomyen, Yotsawat ^a,b   Bhudhisawasdi, Vajarabhongsa ^c   Lertprasertsuke, Nirush ^d   Chotirosniramit, Anon ^d   Pairojkul, Chawalit ^c   Auewarakul, Chirayu U ^e   Sricharunrat, Thaniya ^e   Phornphutkul, Kannika ^f   Sangrajrang, Suleeporn ^g   Cam, Maggie ^a   He, Ping ^h   Hewitt, Stephen M ^a   Ylaya, Kris ^a   Wu, Xiaolin ⁱ   Andersen, Jesper B ^j   Thorgeirsson, Snorri S ^a   Waterfall, Joshua J ^a   Zhu, Yuelin J ^a   Walling, Jennifer ^a   Stevenson, Holly S ^a   Edelman, Daniel ^a   Meltzer, Paul S ^a   Loffredo, Christopher A ^k   Hama, Natsuko ^l   Shibata, Tatsuhiro ^l,m   Wiltrout, Robert H ^a   Harris, Curtis C ^a   Mahidol, Chulabhorn ^b,e   Ruchirawat, Mathuros ^b,n   Wang, Xin W ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b Chulabhorn Research Institute   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

^d Faculty of Medicine Chiang Mai University   (Thailand)

^e CHULABHORN GRADUATE INSTITUTE   (Thailand)

^f Rajavej Hospital   (Thailand)

^g NATIONAL CANCER INSTITUTE   (Thailand)

^h CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

ⁱ FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^l UNIVERSITY OF TOKYO   (Japan)

^m THE UNIVERSITY OF TOKYO   (Japan)

ⁿ THAILAND CENTER OF EXCELLENCE IN PHYSICS   (Thailand)

more..

Author keywords

cancer driver; cancer genomics; hepatocellular carcinoma; integrated genomics; intrahepatic cholangiocarcinoma; liver cancer; metabolomics; molecular subtypes; TIGER LC; transcriptomics

Indexed keywords

PROTEIN P53; RETINOBLASTOMA BINDING PROTEIN 2; TRANSCRIPTOME;

ARTICLE; ASIAN; BILE ACID METABOLISM; BILE DUCT CARCINOMA; CANCER CLASSIFICATION; CANCER PROGNOSIS; COPY NUMBER VARIATION; GENE EXPRESSION; GENE MUTATION; GENOMICS; HUMAN; LIVER CELL CARCINOMA; LYMPHOCYTIC INFILTRATION; METABOLOMICS; MITOSIS; OBESITY; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSCRIPTOMICS; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CLUSTER ANALYSIS; GENETICS; KAPLAN MEIER METHOD; LIVER NEOPLASMS; PROGNOSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CLUSTER ANALYSIS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; PROGNOSIS; TRANSCRIPTOME;

EID: 85021179096     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2017.05.009     Document Type: Article

References (60)

1. Andersen, J.B., Spee, B., Blechacz, B.R., Avital, I., Komuta, M., Barbour, A., Conner, E.A., Gillen, M.C., Roskams, T., Roberts, L.R., et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology 142 (2012), 1021–1031.e15.
2. Banales, J.M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J.B., Invernizzi, P., Lind, G.E., Folseraas, T., Forbes, S.J., Fouassier, L., et al. Expert consensus document. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13 (2016), 261–280.
3. Bridgewater, J., Galle, P.R., Khan, S.A., Llovet, J.M., Park, J.W., Patel, T., Pawlik, T.M., Gores, G.J., Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J. Hepatol. 60 (2014), 1268–1289.
4. Budhu, A., Roessler, S., Zhao, X., Yu, Z., Forgues, M., Ji, J., Karoly, E., Qin, L.X., Ye, Q.H., Jia, H.L., et al. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology 144 (2013), 1066–1075.
5. Calle, E.E., Rodriguez, C., Walker-Thurmond, K., Thun, M.J., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348 (2003), 1625–1638.
6. Cancer Genome Atlas Research Network, Integrated genomic analyses of ovarian carcinoma. Nature 474 (2011), 609–615.
7. Chen, J., Xia, H., Zhang, X., Karthik, S., Pratap, S.V., Ooi, L.L., Hong, W., Hui, K.M., ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma. J. Hepatol. 62 (2015), 1287–1295.
8. Chung, J.Y., Hong, S.M., Choi, B.Y., Cho, H., Yu, E., Hewitt, S.M., The expression of phospho-AKT, phospho-mTOR, and PTEN in extrahepatic cholangiocarcinoma. Clin. Cancer Res. 15 (2009), 660–667.
9. Cohen, J.C., Horton, J.D., Hobbs, H.H., Human fatty liver disease: old questions and new insights. Science 332 (2011), 1519–1523.
10. Cook, D.R., Rossman, K.L., Der, C.J., Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease. Oncogene 33 (2014), 4021–4035.
11. Cross, S.M., Sanchez, C.A., Morgan, C.A., Schimke, M.K., Ramel, S., Idzerda, R.L., Raskind, W.H., Reid, B.J., A p53-dependent mouse spindle checkpoint. Science 267 (1995), 1353–1356.
12. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
13. Devkota, S., Wang, Y., Musch, M.W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D.A., Jabri, B., Chang, E.B., Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487 (2012), 104–108.
14. Dotto, G.P., Rustgi, A.K., Squamous cell cancers: a unified perspective on biology and genetics. Cancer Cell 29 (2016), 622–637.
15. El-Serag, H.B., Hepatocellular carcinoma. N. Engl. J. Med. 365 (2011), 1118–1127.
16. Gu, Z., Eils, R., Schlesner, M., Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32 (2016), 2847–2849.
17. Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I.B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet. 44 (2012), 694–698.
18. Helleday, T., Eshtad, S., Nik-Zainal, S., Mechanisms underlying mutational signatures in human cancers. Nat. Rev. Genet. 15 (2014), 585–598.
19. Hoshida, Y., Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS One, 5, 2010, e15543.
20. Hoshida, Y., Brunet, J.P., Tamayo, P., Golub, T.R., Mesirov, J.P., Subclass mapping: identifying common subtypes in independent disease data sets. PLoS One, 2, 2007, e1195.
21. Hoshida, Y., Nijman, S.M., Kobayashi, M., Chan, J.A., Brunet, J.P., Chiang, D.Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 69 (2009), 7385–7392.
22. Irizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B., Speed, T.P., Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res., 31, 2003, e15.
23. Jiao, Y., Pawlik, T.M., Anders, R.A., Selaru, F.M., Streppel, M.M., Lucas, D.J., Niknafs, N., Guthrie, V.B., Maitra, A., Argani, P., et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat. Genet. 45 (2013), 1470–1473.
24. Kitano, H., Chung, J.Y., Ylaya, K., Conway, C., Takikita, M., Fukuoka, J., Doki, Y., Hanaoka, J., Hewitt, S.M., Profiling of phospho-AKT, phospho-mTOR, phospho-MAPK and EGFR in non-small cell lung cancer. J. Histochem. Cytochem. 62 (2014), 335–346.
25. Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M.J., Sauter, G., Kallioniemi, O.P., Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4 (1998), 844–847.
26. Lee, J.S., Chu, I.S., Heo, J., Calvisi, D.F., Sun, Z., Roskams, T., Durnez, A., Demetris, A.J., Thorgeirsson, S.S., Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40 (2004), 667–676.
27. Lee, J.S., Heo, J., Libbrecht, L., Chu, I.S., Kaposi-Novak, P., Calvisi, D.F., Mikaelyan, A., Roberts, L.R., Demetris, A.J., Sun, Z., et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat. Med. 12 (2006), 410–416.
28. Li, H., Durbin, R., Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25 (2009), 1754–1760.
29. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., Genome Project Data Processing, S., The sequence alignment/map format and SAMtools. Bioinformatics 25 (2009), 2078–2079.
30. McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20 (2010), 1297–1303.
31. Monti, S., Savage, K.J., Kutok, J.L., Feuerhake, F., Kurtin, P., Mihm, M., Wu, B., Pasqualucci, L., Neuberg, D., Aguiar, R.C., et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105 (2005), 1851–1861.
32. Nakamura, H., Arai, Y., Totoki, Y., Shirota, T., Elzawahry, A., Kato, M., Hama, N., Hosoda, F., Urushidate, T., Ohashi, S., et al. Genomic spectra of biliary tract cancer. Nat. Genet. 47 (2015), 1003–1010.
33. Nault, J.C., De Reynies, A., Villanueva, A., Calderaro, J., Rebouissou, S., Couchy, G., Decaens, T., Franco, D., Imbeaud, S., Rousseau, F., et al. A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. Gastroenterology 145 (2013), 176–187.
34. Newman, A.M., Liu, C.L., Green, M.R., Gentles, A.J., Feng, W., Xu, Y., Hoang, C.D., Diehn, M., Alizadeh, A.A., Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12 (2015), 453–457.
35. Niiya, F., Tatsumoto, T., Lee, K.S., Miki, T., Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA. Oncogene 25 (2006), 827–837.
36. Oishi, N., Kumar, M.R., Roessler, S., Ji, J., Forgues, M., Budhu, A., Zhao, X., Andersen, J.B., Ye, Q.H., Jia, H.L., et al. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 56 (2012), 1792–1803.
37. Ong, C.K., Subimerb, C., Pairojkul, C., Wongkham, S., Cutcutache, I., Yu, W., McPherson, J.R., Allen, G.E., Ng, C.C., Wong, B.H., et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat. Genet. 44 (2012), 690–693.
38. Park, E.J., Lee, J.H., Yu, G.Y., He, G., Ali, S.R., Holzer, R.G., Osterreicher, C.H., Takahashi, H., Karin, M., Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140 (2010), 197–208.
39. Roessler, S., Jia, H.L., Budhu, A., Forgues, M., Ye, Q.H., Lee, J.S., Thorgeirsson, S.S., Sun, Z., Tang, Z.Y., Qin, L.X., et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 70 (2010), 10202–10212.
40. Roessler, S., Long, E.L., Budhu, A., Chen, Y., Zhao, X., Ji, J., Walker, R., Jia, H.L., Ye, Q.H., Qin, L.X., et al. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology 142 (2012), 957–966.
41. Roessler, S., Lin, G., Forgues, M., Budhu, A., Hoover, S., Simpson, R.M., Wu, X., He, P., Qin, L.X., Tang, Z.Y., et al. Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma. Int. J. Biol. Sci. 11 (2015), 88–98.
42. Saunders, C.T., Wong, W.S., Swamy, S., Becq, J., Murray, L.J., Cheetham, R.K., Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28 (2012), 1811–1817.
43. Sia, D., Hoshida, Y., Villanueva, A., Roayaie, S., Ferrer, J., Tabak, B., Peix, J., Sole, M., Tovar, V., Alsinet, C., et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 144 (2013), 829–840.
44. Sripa, B., Kaewkes, S., Sithithaworn, P., Mairiang, E., Laha, T., Smout, M., Pairojkul, C., Bhudhisawasdi, V., Tesana, S., Thinkamrop, B., et al. Liver fluke induces cholangiocarcinoma. PLoS Med., 4, 2007, e201.
45. Strebhardt, K., Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat. Rev. Drug Discov. 9 (2010), 643–660.
46. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005), 15545–15550.
47. Theise, N.D., Liver Cancer. 2014, International Agency for Research on Cancer.
48. Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., Schoonjans, K., Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 7 (2008), 678–693.
49. Totoki, Y., Tatsuno, K., Covington, K.R., Ueda, H., Creighton, C.J., Kato, M., Tsuji, S., Donehower, L.A., Slagle, B.L., Nakamura, H., et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat. Genet. 46 (2014), 1267–1273.
50. Vigil, D., Cherfils, J., Rossman, K.L., Der, C.J., Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?. Nat. Rev. Cancer 10 (2010), 842–857.
51. Wang, X.W., Thorrgeirsson, S.S., The Biological and clinical challenge of liver cancer heterogeneity. Hepatic Oncol., 1, 2014, 5.
52. Welzel, T.M., Graubard, B.I., Zeuzem, S., El-Serag, H.B., Davila, J.A., McGlynn, K.A., Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 54 (2011), 463–471.
53. Wilkerson, M.D., Hayes, D.N., ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26 (2010), 1572–1573.
54. Woo, H.G., Park, E.S., Lee, J.S., Lee, Y.H., Ishikawa, T., Kim, Y.J., Thorgeirsson, S.S., Identification of potential driver genes in human liver carcinoma by genomewide screening. Cancer Res. 69 (2009), 4059–4066.
55. Woo, H.G., Lee, J.H., Yoon, J.H., Kim, C.Y., Lee, H.S., Jang, J.J., Yi, N.J., Suh, K.S., Lee, K.U., Park, E.S., et al. Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. Cancer Res. 70 (2010), 3034–3041.
56. Worns, M.A., Galle, P.R., HCC therapies – lessons learned. Nat. Rev. Gastroenterol. Hepatol. 11 (2014), 447–452.
57. Yamashita, T., Forgues, M., Wang, W., Kim, J.W., Ye, Q., Jia, H., Budhu, A., Zanetti, K.A., Chen, Y., Qin, L.X., et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res. 68 (2008), 1451–1461.
58. Ye, Q.H., Qin, L.X., Forgues, M., He, P., Kim, J.W., Peng, A.C., Simon, R., Li, Y., Robles, A.I., Chen, Y., et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat. Med. 9 (2003), 416–423.
59. Yim, H., Current clinical trials with polo-like kinase 1 inhibitors in solid tumors. Anticancer Drugs 24 (2013), 999–1006.
60. Yoshimoto, S., Loo, T.M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499 (2013), 97–101.